

DexCom (NASDAQ:DXCM) reported third-quarter financial results on Thursday. The transcript from the company’s third-quarter earnings call has been provided...
You can purchase shares of DexCom (NASDAQ:DXCM) through any online brokerage.
Other companies in DexCom’s space includes: Abbott Laboratories (NYSE:ABT), Intuitive Surgical Inc (NASDAQ:ISRG), Medtronic PLC (NYSE:MDT), Stryker Corp (NYSE:SYK) and Boston Scientific Corp (NYSE:BSX).
DexCom has a consensus price target of $92.27.
The stock price for DexCom (NASDAQ: DXCM) is $84.299526 last updated November 5, 2026 at 5:30 PM EST.
There are no upcoming dividends for DexCom.
DexCom does not have any upcoming earnings scheduled.
There is no upcoming split for DexCom.
DexCom is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.
DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with...